APA (7th ed.) Citation

Saalfeld, F., Wenzel, C., Christopoulos, P., Merkelbach-Bruse, S., Reissig, T. M., Laßmann, S., . . . Wermke, M. (2021). Efficacy of immune checkpoint inhibitors alone or in combination with chemotherapy in NSCLC harboring ERBB2 mutations. Journal of thoracic oncology, 16(11), . https://doi.org/10.1016/j.jtho.2021.06.025

Chicago Style (17th ed.) Citation

Saalfeld, Felix, et al. "Efficacy of Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy in NSCLC Harboring ERBB2 Mutations." Journal of Thoracic Oncology 16, no. 11 (2021). https://doi.org/10.1016/j.jtho.2021.06.025.

MLA (9th ed.) Citation

Saalfeld, Felix, et al. "Efficacy of Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy in NSCLC Harboring ERBB2 Mutations." Journal of Thoracic Oncology, vol. 16, no. 11, 2021, https://doi.org/10.1016/j.jtho.2021.06.025.